Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Correction

Correction to: the impact of pharmacokinetic gene profiles across human cancers

Authors: Michael T. Zimmermann, Terry M. Therneau, Jean-Pierre A. Kocher

Published in: BMC Cancer | Issue 1/2018

Login to get access

Excerpt

It has been highlighted that in the original manuscript [1] Fig. 1 was omitted and Fig. 2 appeared twice. This Correction article shows the correct Fig. 1. The original article has been updated.
Literature
Metadata
Title
Correction to: the impact of pharmacokinetic gene profiles across human cancers
Authors
Michael T. Zimmermann
Terry M. Therneau
Jean-Pierre A. Kocher
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4593-1

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine